These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35816693)

  • 1. Micrococcin P2 Targets
    Son YJ; Kim YR; Oh SH; Jung S; Ciufolini MA; Hwang HJ; Kwak JH; Pai H
    J Nat Prod; 2022 Aug; 85(8):1928-1935. PubMed ID: 35816693
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Oka D; Yamaya N; Kuno T; Asakawa Y; Shiragiku T; Chen L; Xue J; Mamuti A; Ye F; Sun J; Ohguro K; Miyamoto H; Uematsu Y; Inagaki K; Cheng JF; Matsumoto M
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33495229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target
    Kim D; Kim YR; Hwang HJ; Ciufolini MA; Lee J; Lee H; Clovis S; Jung S; Oh SH; Son YJ; Kwak JH
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of the novel antibacterial agent ibezapolstat (ACX-362E) against Clostridioides difficile.
    Murray B; Wolfe C; Marra A; Pillar C; Shinabarger D
    J Antimicrob Chemother; 2020 Aug; 75(8):2149-2155. PubMed ID: 32285102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of Circulating
    Martínez-Meléndez A; Tijerina-Rodríguez L; Collins N; Baines SD; Morfin-Otero R; Camacho-Ortíz A; Villarreal-Treviño L; Garza-González E
    Microb Drug Resist; 2021 Dec; 27(12):1672-1676. PubMed ID: 34037477
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Begum K; Bassères E; Miranda J; Lancaster C; Gonzales-Luna AJ; Carlson TJ; Rashid T; Eyre DW; Wilcox MH; Alam MJ; Garey KW
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of eravacycline against common ribotypes of Clostridioides difficile.
    Bassères E; Begum K; Lancaster C; Gonzales-Luna AJ; Carlson TJ; Miranda J; Rashid T; Alam MJ; Eyre DW; Wilcox MH; Garey KW
    J Antimicrob Chemother; 2020 Oct; 75(10):2879-2884. PubMed ID: 32719870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
    Karlowsky JA; Adam HJ; Baxter MR; Dutka CW; Nichol KA; Laing NM; Golding GR; Zhanel GG
    J Antimicrob Chemother; 2020 Jul; 75(7):1824-1832. PubMed ID: 32294172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile.
    Turner NA; Warren BG; Gergen-Teague MF; Addison RM; Addison B; Rutala WA; Weber DJ; Sexton DJ; Anderson DJ
    Clin Infect Dis; 2022 Mar; 74(4):648-656. PubMed ID: 34017999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of fidaxomicin on biofilm formation in Clostridioides difficile.
    Hamada M; Yamaguchi T; Ishii Y; Chono K; Tateda K
    J Infect Chemother; 2020 Jul; 26(7):685-692. PubMed ID: 32224190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection.
    Abutaleb NS; Seleem MN
    Sci Rep; 2020 May; 10(1):7701. PubMed ID: 32382070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple Clostridioides difficile Infection Recurrences.
    Skinner AM; Tan X; Sirbu BD; Danziger LH; Gerding DN; Johnson S
    Clin Infect Dis; 2021 Sep; 73(6):1107-1109. PubMed ID: 33714998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile.
    Collins DA; Wu Y; Tateda K; Kim HJ; Vickers RJ; Riley TV
    J Antimicrob Chemother; 2021 Mar; 76(4):967-972. PubMed ID: 33351917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrapotent Inhibitor of
    Naclerio GA; Abutaleb NS; Li D; Seleem MN; Sintim HO
    J Med Chem; 2020 Oct; 63(20):11934-11944. PubMed ID: 32960605
    [No Abstract]   [Full Text] [Related]  

  • 17. Clostridioides (Clostridium) difficile in children with diarrhoea in Vietnam.
    Khun PA; Phi LD; Pham PT; Thu Nguyen HT; Huyen Vu QT; Collins DA; Riley TV
    Anaerobe; 2022 Apr; 74():102550. PubMed ID: 35331913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile.
    Phanchana M; Phetruen T; Harnvoravongchai P; Raksat P; Ounjai P; Chankhamhaengdecha S; Janvilisri T
    Sci Rep; 2020 Apr; 10(1):6497. PubMed ID: 32300130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Clostridium difficile biofilms: imaging and antimicrobial treatment.
    James GA; Chesnel L; Boegli L; deLancey Pulcini E; Fisher S; Stewart PS
    J Antimicrob Chemother; 2018 Jan; 73(1):102-108. PubMed ID: 29029221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.
    Wang S; Zhu D; Sun X
    Microbiol Spectr; 2022 Jun; 10(3):e0026322. PubMed ID: 35583336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.